|
Volumn 61, Issue 4, 2015, Pages 1435-1436
|
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
APIXABAN;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
RIVAROXABAN;
THROMBOMODULIN;
MORPHOLINE DERIVATIVE;
THIOPHENE DERIVATIVE;
ANTICOAGULANT THERAPY;
ANTICOAGULATION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
IN VITRO STUDY;
LETTER;
LIVER CIRRHOSIS;
LIVER FUNCTION;
PORTAL VEIN THROMBOSIS;
PRIORITY JOURNAL;
THROMBIN TIME;
HUMAN;
MALE;
MESENTERIC VEIN;
PORTAL VEIN;
VENOUS THROMBOSIS;
ANTICOAGULANTS;
HUMANS;
MALE;
MESENTERIC VEINS;
MORPHOLINES;
PORTAL VEIN;
THIOPHENES;
VENOUS THROMBOSIS;
|
EID: 84925371532
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.27350 Document Type: Letter |
Times cited : (45)
|
References (6)
|